TECNIS Multifocal Foldable Acrylic Intraocular Lens, Model No. ZMA00 The product is indicated fo...

FDA Device Recall #Z-2863-2016 — Class II — August 26, 2016

Recall Summary

Recall Number Z-2863-2016
Classification Class II — Moderate risk
Date Initiated August 26, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Medical Optics Inc. (AMO)
Location Santa Ana, CA
Product Type Devices
Quantity 41 units

Product Description

TECNIS Multifocal Foldable Acrylic Intraocular Lens, Model No. ZMA00 The product is indicated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in whom a cataractous lens has been removed by extracapsular cataract extraction and who desire near, intermediate, and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag

Reason for Recall

Abbott Medical Optics is recalling Intraocular Lenses (IOLs) because they were not being checked prior to release and this may result in the release of mislabeled IOLs.

Distribution Pattern

Worldwide Distribution - US nationwide, PR, and Internationally to Canada, Latin America, Europe, Africa, Middle East, and Asia Pacific.

Lot / Code Information

Serial No. 8213991504 8214001504 8214011504 8214021504 8214031504 8214041504 8214051504 8214061504 8214071504 8214101504 8538801603 8538821603 8538831603 8538841603 8538871603 8538891603 8538901603 8538971603 8538981603 8416821507 8416831507 8416841507 8416851507 8416911507 8416921507 8416951507 8416961507 8416971507 8416991507 8417001507 8417011507 8417021507 8417041507 8417071507 8417081507 8417091507 8417101507 8445191507 8505901605 8505911605 8505961605

Other Recalls from Abbott Medical Optics Inc. (AMO)

Recall # Classification Product Date
Z-2064-2017 Class II Healon Duet, Part No. 10290080, 10220010, 10220... Apr 1, 2017
Z-2062-2017 Class II Healon, Part No. 10290953, 10295210, 10200011, ... Apr 1, 2017
Z-2063-2017 Class II Healon GV, Part No. 10294701, 10294801, 1020001... Apr 1, 2017
Z-2065-2017 Class II Healon 5 Pro, Part No. 10270015 Apr 1, 2017
Z-2066-2017 Class II Healon Pro, Part No. 10270012 Apr 1, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.